Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab

Publication date: Available online 11 July 2018Source: Multiple Sclerosis and Related DisordersAuthor(s): Aala Darki, Peiman Masoumi, Abbas Soleimani, Abdorreza Naser MoghadasiAbstractNatalizumab is among the most effective drugs for controlling multiple sclerosis (MS). The most important side effect of this drug is progressive multifocal leukoencephalopathy, although some other complications are increasingly reported in literature such as meningitis and encephalitis. Here, a patient with MS who has suffered from myocardial infarction (MI) after the injection of natalizumab is introduced.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research